邱璽錚經營瑞寶工程已有2年1個月,統一編號:50740992在2017-05-12成立於花蓮縣吉安鄉仁里村仁里五街11巷18號1樓販賣電焊工程業|防蝕、防銹工程業|其他工程業|建材批發業...等商品·技術·服務詳細工商資訊完整紀錄。
李世強經營瑞寶生物科技有限公司已有7年5個月,統一編號:53980329在2012-09-04成立於臺中市北屯區水湳里文心路四段81號12樓之1販賣飲料店業|其他餐飲業|管理顧問業|產業育成業...等商品·技術·服務詳細工商資訊完整紀錄。
摘錄2018/01/08 經濟日報瑞寶基因公告泰國通過該公司疫苗查驗登記，積極籌備產品上市，推動行... more >. 2018 / 02 / 02. 最新養豬調查出爐！我國仍處於危險的缺豬狀態! 摘錄2018/01/22 聯合報最新養豬調查出爐！我國仍處於危險的缺豬狀態! 每年5月、11月農委會進行... more >. 2018 / 02 / 02. 公告本公司寬活豬生殖與呼吸綜合 ...
Market Code Company Name Industry Symbol Date of Listing Chairman General Manager Spokesman Title of Spokesman Fiscal Year_end Accounting Firm CPA (Chartered Public Accountant)1 CPA (Chartered Public Accountant)2 Address Telephone Fax Email ...
Sale Results 5 Polled Hereford Commercial Replacement Heifers: Copper-T Ranch, Fraser Lake $1,650.00 each 5 Black Baldy Commercial Replacement Heifers: Vallee Creek Ranch, Houston $1,550.00 each 5 Red Angus Commercial Replacement Heifers: Matt ...
9781846821219 1846821215 Virtues of a Wicked Earl - The Life and Legend of William Sydney Clements, 3rd Earl of Leitrim, 1806-78, A.P.W. Malcomson 9781402088995 140208899X Methods of Cancer Diagnosis, Therapy and Prognosis - Gastrointestinal Cancer, M. A.
Reber Genetics was founded in 2008 with the objective of becoming a successful biotechnology company devoted to innovative R&D and high-quality products.
Reber Genetics was founded in 2008 with the objective of becoming a successful biotechnology company devoted to innovative R&D and high-quality products.
REBER GENETICS. STAKEHOLDER. > STAKEHOLDER. About Us. 10685 3F, No.25-1, Sec. 4, Ren Ai Rd., Taipei, Taiwan, R.O.C.. Tel: +886-2-27313191
President Hsiu-Kang Chang graduated from the School of Pharmacy, Taipei Medical University, and has a professional pharmacist license. He started business ...
REBER GENETICS CO LTD is a Taiwan-based company mainly engaged in the research and development, manufacture and distribution of animal vaccines.
Reber Genetics Co., Ltd. focuses on the research, development, and production of animal vaccines in Taiwan. The company's sub-unit vaccine development ...